121 related articles for article (PubMed ID: 1115121)
1. Cellular hypersensitivity in patients with squamous cell carcinoma of the cervix.
Chen SS; Koffler D; Cohen CJ
Am J Obstet Gynecol; 1975 Jan; 121(1):91-5. PubMed ID: 1115121
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunity in patients with ovarian carcinoma.
Chen SY; Koffler D; Cohen CJ
Am J Obstet Gynecol; 1973 Feb; 115(4):467-70. PubMed ID: 4346615
[No Abstract] [Full Text] [Related]
3. Cellular hypersensitivity in patients with adenomatous hyperplasia and adenocarcinoma of the endometrium.
Chen SY; Cohen CJ; Koffler D
Am J Obstet Gynecol; 1976 Oct; 126(3):370-3. PubMed ID: 986771
[TBL] [Abstract][Full Text] [Related]
4. Relation of cell-mediated immunity in women with genital tract cancer to origin, histology, clinical stage and subsequent behaviour of neoplasm.
Khoo SK; Mackay EV
J Obstet Gynaecol Br Commonw; 1974 Mar; 81(3):229-35. PubMed ID: 4821482
[No Abstract] [Full Text] [Related]
5. Cell-mediated immune reaction to two gynecologic malignant tumors.
DiSala PJ; Rutledge FN; Smith JP; Sinkovics JG
Cancer; 1971 Nov; 28(5):1129-37. PubMed ID: 5125661
[No Abstract] [Full Text] [Related]
6. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
[No Abstract] [Full Text] [Related]
7. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
Wells SA; Melewicz FC; Christiansen C; Ketcham AS
Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
[No Abstract] [Full Text] [Related]
8. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
Bhattacharya M; Barlow JJ
Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
[No Abstract] [Full Text] [Related]
9. Immunologic response in gynecologic malignancy as demonstrated by the delayed hypersensitivity reaction: clinical correlations.
Nalick RH; DiSaia PJ; Rea TH; Morrow MH
Am J Obstet Gynecol; 1974 Feb; 118(3):393-405. PubMed ID: 4358924
[No Abstract] [Full Text] [Related]
10. Virus-augmented delayed hypersensitivity skin tests in gynecological malignancies.
Freedman RS; Bowen JM; Atkinson EN; Scott W; Wagner S
Cancer Immunol Immunother; 1984; 17(2):142-6. PubMed ID: 6088033
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
Dini MM; Jafari K; Faiferman I
Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated antigens in gynecologic cancer.
DiSaia PJ
Clin Obstet Gynecol; 1975 Dec; 18(4):87-108. PubMed ID: 765038
[TBL] [Abstract][Full Text] [Related]
13. Immunological aspects of gynecological malignancies.
DiSaia PJ
J Reprod Med; 1975 Jan; 14(1):17-20. PubMed ID: 1110478
[TBL] [Abstract][Full Text] [Related]
14. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
Ishiwata I; Ishiwata C
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
[No Abstract] [Full Text] [Related]
15. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.
Ueda G; Inoue Y; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Saito J; Nishino T; Abe Y
Int J Gynecol Pathol; 1984; 3(3):291-8. PubMed ID: 6389386
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of leukocyte adherence by potassium chloride extract of allogeneic squamous cell carcinoma of the human uterine cervix.
Dini MM; Lenzi L; Faiferman I
Am J Reprod Immunol (1980); 1983 Jun; 3(4):188-90. PubMed ID: 6881415
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte migration enhancement as an indicator of immunologic enhancement. II. Malignancy.
Gleicher N; Beers P; Kerenyi TD; Gusberg SB
Am J Obstet Gynecol; 1980 Jan; 136(1):126-31. PubMed ID: 7352475
[TBL] [Abstract][Full Text] [Related]
18. Cellular immunity as a host response to squamous carcinoma of the cervix.
Goldstein MS; Shore B; Gusberg SB
Am J Obstet Gynecol; 1971 Nov; 111(6):751-5. PubMed ID: 5166388
[No Abstract] [Full Text] [Related]
19. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
Gocze PM; Vahrson HW; Freeman DA
Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
[TBL] [Abstract][Full Text] [Related]
20. [Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix].
Göcze P; Vahrson H
Orv Hetil; 1992 Dec; 133(50):3191-4. PubMed ID: 1461640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
